• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号
首页- Products - Others - Other Targets - Pseudolaric acid B-glucopyranoside

Pseudolaric acid B-glucopyranoside

CAS No. 98891-41-9

Pseudolaric acid B-glucopyranoside ( —— )

产品货号. M20505 CAS No. 98891-41-9

Pseudolaric acid B-glucopyranoside is a natural product from Pseudolarix amabilis.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥478 有现货
5MG ¥778 有现货
10MG ¥1337 有现货
25MG ¥2584 有现货
50MG ¥3880 有现货
100MG ¥5573 有现货
200MG ¥7752 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Pseudolaric acid B-glucopyranoside
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Pseudolaric acid B-glucopyranoside is a natural product from Pseudolarix amabilis.
  • 产品描述
    Pseudolaric acid B-glucopyranoside is a natural product from Pseudolarix amabilis.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Others
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    98891-41-9
  • 分子量
    594.6
  • 分子式
    C29H38O13
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    COC(=O)C1=CC[C@]23CC[C@H]([C@]2(CC1)OC(C)=O)[C@](C)(OC3=O)\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Peng L Hong-Zhu G Jiang-Hao S et al. Metabolic pathway and metabolites of total diterpene acid isolated from Pseudolarix kaempferi[J]. Acta Pharmaceutica Sinica 2014.
产品手册
关联产品
  • Dichotomine B

    Dichotomine B is a natural product of Stellaria, Caryophyllaceae. Dichotomine B can be used as a reference standard.

  • 3-O-Methylducheside ...

    3-O-Methylducheside A is a natural product for research related to life sciences.

  • Examorelin

    Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?